Signal #119153 · SEC 8-K

$SYRE SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $SYRE filing catalyst

Why did $SYRE trigger an AI stock catalyst alert?

$SYRE triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Spyre Therapeutics Reports Positive Phase 2 SPY003 Data and Q3 Results. Key points: - Reported positive topline induction data for SPY003 in Phase 2 SKYLINE trial, completing PoC for three IBD monotherapies. - SKYLINE Part B enrollment progressing ahead of schedule with results expected Q3 2027. - Balance sheet shows over $1.09B in total assets and cash/equivalents of $82.7M.

How did $SYRE stock react after the SEC filing?

After the SEC 8-K for $SYRE, observed market reaction: T0 price $99.27. Past moves do not guarantee future results.

Where can I get real-time $SYRE SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $SYRE via Telegram and the VIP Web Terminal from €10/month.

$SYRE

$SYRE – Spyre Therapeutics Reports Positive Phase 2 SPY003 Data and Q3 Results

Spyre Therapeutics, Inc.

2026-11-03 00:00:00 UTC · SEC 8-K · All $SYRE

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

Reported positive topline induction data for SPY003 in Phase 2 SKYLINE trial, completing PoC for three IBD monotherapies.
SKYLINE Part B enrollment progressing ahead of schedule with results expected Q3 2027.
Balance sheet shows over $1.09B in total assets and cash/equivalents of $82.7M.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →